Iris Acquisition Holdings LLC
CIK: 0002064461
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LIMN
Liminatus Pharma, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Iris Acquisition Holdings LLC
Iris Acquisition Holdings LLC (SEC CIK 0002064461) files insider reports with the SEC as 10% Owner of Liminatus Pharma, Inc. (LIMN).
Signal8 holds 1 ownership filing by Iris Acquisition Holdings LLC, a Form 3, filed on Aug 15, 2025. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Iris Acquisition Holdings LLC's filings is in GEORGE TOWN, E9.
Other insiders filing for Liminatus Pharma, Inc. (LIMN)
- Valetudo Therapeutics LLC, 10% Owner
- Ewon Comfortech Co., Ltd., 10% Owner
- Lemons II Philip Wayne, Director
- Baek Richard JaiHwan, Director
- KH Feelux Co., Ltd, 10% Owner
- Lee Eun Sook, Director